Majid, Bayanan C.

HRN: 23-13-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
CEFTAZIDIME 1GM (VIAL)
10/10/2025
10/16/2025
IV
2 Grams
Q8
Cap Mr
Checking Final Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines